Covance To Open Its Own Preclinical Facility In Shanghai After Abandoning Plans To Create Joint Drug Testing Facility With WuXi
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Princeton-headquartered contact research organization Covance is investing $20-25 million to build a preclinical laboratory in Shanghai, the company's second such research facility in Shanghai